{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:42:36Z","timestamp":1789954956937,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T00:00:00Z","timestamp":1251417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10689-009-9287-z","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T06:07:28Z","timestamp":1251353248000},"page":"563-567","source":"Crossref","is-referenced-by-count":32,"title":["The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30"],"prefix":"10.1007","volume":"8","author":[{"given":"Ophira M.","family":"Ginsburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parviz","family":"Ghadirian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Robidoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Londono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Magalhaes","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine","family":"Dimitrakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Pilarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,28]]},"reference":[{"key":"9287_CR1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","volume":"4","author":"SA Narod","year":"2004","unstructured":"Narod SA, Foulkes WD (2004) BRCA1 and BRCA2; 1994 and beyond. Nat Rev Cancer 4:665\u2013676","journal-title":"Nat Rev Cancer"},{"key":"9287_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-71-4-747","volume":"71","author":"FP Li","year":"1969","unstructured":"Li FP, Fraumeni JF Jr (1969) Soft tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med 71:747\u2013752","journal-title":"Ann Intern Med"},{"key":"9287_CR3","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li FP, Fraumeni JF Jr, Mulvihill JJ et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358\u20135362","journal-title":"Cancer Res"},{"key":"9287_CR4","first-page":"6069","volume":"51","author":"JE Garber","year":"1991","unstructured":"Garber JE, Goldstein AM, Kantor AF et al (1991) Follow up study of twenty-four families with Li-Fraumeni syndrome. Cancer Res 51:6069\u20136097","journal-title":"Cancer Res"},{"key":"9287_CR5","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin D, Li FP, Strong LC et al (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcoma, and other neoplasms. Science 250:1233\u20131238","journal-title":"Science"},{"key":"9287_CR6","first-page":"1298","volume":"54","author":"JM Birch","year":"1994","unstructured":"Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54:1298\u20131304","journal-title":"Cancer Res"},{"issue":"7","key":"9287_CR7","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.clon.2007.05.001","volume":"19","author":"A Salmon","year":"2007","unstructured":"Salmon A, Amikam D, Sodha N, Davidson S, Basel-Vanagaite L, Eeles RA, Abeliovich D, Peretz T (2007) Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline \u2018de-novo\u2019 TP53 mutation. Clin Oncol (R Coll Radiol) 19(7):490\u2013493","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"9287_CR8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ijc.10194","volume":"98","author":"ML Leon Matsuda De","year":"2002","unstructured":"De Leon Matsuda ML, Liede A, Kwan E, Mapua CA, Cutiongco EM, Tan A, Borg A, Narod SA (2002) BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int J Cancer 98(4):596\u2013603","journal-title":"Int J Cancer"},{"issue":"3","key":"9287_CR9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1086\/342506","volume":"71","author":"A Liede","year":"2002","unstructured":"Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA (2002) Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 71(3):595\u2013606","journal-title":"Am J Hum Genet"},{"issue":"3","key":"9287_CR10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-006-9378-6","volume":"103","author":"MC Gomes","year":"2007","unstructured":"Gomes MC, Costa MM, Borojevic R, Monteiro AN, Vieira R, Koifman S, Koifman RJ, Li S, Royer R, Zhang S, Narod SA (2007) Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil. Breast Cancer Res Treat 103(3):349\u2013353","journal-title":"Breast Cancer Res Treat"},{"key":"9287_CR11","first-page":"365","volume-title":"Bioinformatics methods and protocols: methods in molecular biology","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky HJ (2000) Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics methods and protocols: methods in molecular biology. Humana Press, New Jersey, pp 365\u2013386"},{"issue":"3","key":"9287_CR12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cmb.1997.4.311","volume":"4","author":"MG Reese","year":"1997","unstructured":"Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4(3):311\u2013323","journal-title":"J Comput Biol"},{"issue":"16","key":"9287_CR13","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/hmg\/ddl171","volume":"15","author":"PJ Smith","year":"2006","unstructured":"Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006) An increased specificity score matrix for the prediction of SF2\/ASF-specific exonic splicing enhancers. Hum Mol Genet 15(16):2490\u20132508","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9287_CR14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ejca.2006.09.024","volume":"43","author":"S Manoukian","year":"2007","unstructured":"Manoukian S, Peissel B, Pensotti V et al (2007) Germline mutations of TP53 and BRCA2 genes in breast cancer\/sarcoma families. Eur J Cancer 43(3):601\u2013606","journal-title":"Eur J Cancer"},{"issue":"2","key":"9287_CR15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2006.02.004","volume":"342","author":"ME Krasteva","year":"2006","unstructured":"Krasteva ME, Georgieva EI (2006) Germline p53 single-base changes associated with Balkan endemic nephropathy. Biochem Biophys Res Commun 342(2):562\u2013567","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"9287_CR16","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1136\/jmg.2003.015594","volume":"41","author":"G Keller","year":"2004","unstructured":"Keller G, Vogelsang H, Becker I et al (2004) Germline mutations of the E-cadherin (CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. J Med Genet 41(6):e89","journal-title":"J Med Genet"},{"issue":"2","key":"9287_CR17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/carcin\/bgl132","volume":"28","author":"LR Dearth","year":"2007","unstructured":"Dearth LR, Qian H, Wang T et al (2007) Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers. Carcinogenesis 28(2):289\u2013298","journal-title":"Carcinogenesis"},{"issue":"1","key":"9287_CR18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1074\/jbc.M310815200","volume":"279","author":"K Shiraishi","year":"2004","unstructured":"Shiraishi K, Kato S, Han SY et al (2004) Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library. J Biol Chem 279(1):348\u2013355","journal-title":"J Biol Chem"},{"issue":"17","key":"9287_CR19","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1073\/pnas.1633803100","volume":"100","author":"MA Resnick","year":"2003","unstructured":"Resnick MA, Inga A (2003) Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity. Proc Natl Acad Sci USA 100(17):9934\u20139939","journal-title":"Proc Natl Acad Sci USA"},{"issue":"34","key":"9287_CR20","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1038\/sj.onc.1206511","volume":"22","author":"P Monti","year":"2003","unstructured":"Monti P, Campomenosi P, Ciribilli Y et al (2003) Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay. Oncogene 22(34):5252\u20135260","journal-title":"Oncogene"},{"issue":"27","key":"9287_CR21","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1038\/sj.onc.1204428","volume":"20","author":"D Maurici","year":"2001","unstructured":"Maurici D, Monti P, Campomenosi P et al (2001) Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 20(27):3533\u20133540","journal-title":"Oncogene"},{"issue":"15","key":"9287_CR22","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/sj.onc.1202565","volume":"18","author":"PD Smith","year":"1999","unstructured":"Smith PD, Crossland S, Parker G et al (1999) Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18(15):2451\u20132459","journal-title":"Oncogene"},{"issue":"10","key":"9287_CR23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/sj.onc.1201889","volume":"16","author":"JM Flaman","year":"1998","unstructured":"Flaman JM, Robert V, Lenglet S et al (1998) Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16(10):1369\u20131372","journal-title":"Oncogene"},{"key":"9287_CR24","doi-asserted-by":"crossref","unstructured":"Tinat J, Bougeard G, Baert-Desurmont et al (2009) 2009 version of the Chompret criteria for Li-Fraumeni syndrome. J Clin Oncol (Epub August)","DOI":"10.1200\/JCO.2009.22.7967"},{"key":"9287_CR25","first-page":"3234","volume":"52","author":"A-L Borresen","year":"1992","unstructured":"Borresen A-L, Andersen TI, Garber J et al (1992) Screening for germ line TP53 mutations in breast cancer patients. Cancer Res 52:3234\u20133236","journal-title":"Cancer Res"},{"key":"9287_CR26","first-page":"10","volume":"25","author":"RA Eeles","year":"1995","unstructured":"Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25:10\u201324","journal-title":"Cancer Surv"},{"key":"9287_CR27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.ejca.2005.11.032","volume":"42","author":"F Laloo","year":"2006","unstructured":"Laloo F, Varley J, Moran A et al (2006) BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur J Cancer 42:1143\u20131150","journal-title":"Eur J Cancer"},{"key":"9287_CR28","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1200\/JCO.2008.16.6959","volume":"27","author":"KD Gonzalez","year":"2009","unstructured":"Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fung CY, Nguyen Q, Han JH et al (2009) Beyond Li-Fraumeni syndrome, clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250\u20131256","journal-title":"J Clin Oncol"},{"issue":"8","key":"9287_CR29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/jmg.2008.057570","volume":"45","author":"G Bougeard","year":"2008","unstructured":"Bougeard G, Sesboue R, Baert-Desurmont S et al (2008) Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families. J Med Genet 45(8):535\u2013538","journal-title":"J Med Genet"},{"key":"9287_CR30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jmg.2007.054494","volume":"45","author":"DG Evans","year":"2008","unstructured":"Evans DG, Wu CL, Birch JM (2008) BRCA2: a cause of the Li-Fraumeni like syndrome. J Med Genet 45:62\u201363","journal-title":"J Med Genet"},{"issue":"12","key":"9287_CR31","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","volume":"295","author":"T Walsh","year":"2006","unstructured":"Walsh T, Casadei S, Coats KH et al (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2 and TP53 in families at high risk of breast cancer. JAMA 295(12):1379\u20131388","journal-title":"JAMA"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9287-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-009-9287-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-009-9287-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T17:46:00Z","timestamp":1559238360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-009-9287-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,28]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9287"],"URL":"https:\/\/doi.org\/10.1007\/s10689-009-9287-z","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,28]]}}}